We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
[Epidemiology of avoidable delay in the treatment of acute myocardial infarct: study conducted by "GISSI" (Italian Group for the Study of Survival after Myocardial Infarct)].
Giornale Italiano di Cardiologia 1996 July
AIM OF THE STUDY: The delay between onset of symptoms and coronary care unit admission is decisive in the outcome of patients with acute myocardial infarction. The objective of the GISSI-Avoidable Delay Study was to evaluate the influence of the factors that affect the delay in acute myocardial infarction treatment.
METHODS: This study was a nationwide multicentre case-control study conducted in Italy by the 118 Coronary Care Units (CCUs) participating in GISSI-network. The median and mean times in cases and controls were compared for decision time, home-to-hospital time, and in-hospital time, and the influence of several potential risk factors on the delay was evaluated by comparison of patients admitted more than 6 hours after onset of symptoms with those admitted within 6 hours after onset. Among 5301 patients with acute myocardial infarction, 590 who came to a coronary care unit after 12 hours were considered cases. Controls included 600 patients treated within 2 hours, 603 between 2 and 6 hours, and 466 between 6 and 12 hours.
RESULTS: The median decision time among cases was 50-fold higher than that of controls who presented within 2 hours. Home-to-hospital time and in-hospital time appeared to play a less important role. Considering the patient-related variables, the delay seemed to be significantly affected by advanced age, living alone, low intensity of initial symptoms, history of diabetes, strong pain at onset of the infarction, occurrence of symptoms at night, and involvement of a general practitioner.
CONCLUSIONS: These data suggest that interventions aimed at reducing the delay in acute myocardial infarction treatment should primarly focus on the help-seeking behaviour of patients.
METHODS: This study was a nationwide multicentre case-control study conducted in Italy by the 118 Coronary Care Units (CCUs) participating in GISSI-network. The median and mean times in cases and controls were compared for decision time, home-to-hospital time, and in-hospital time, and the influence of several potential risk factors on the delay was evaluated by comparison of patients admitted more than 6 hours after onset of symptoms with those admitted within 6 hours after onset. Among 5301 patients with acute myocardial infarction, 590 who came to a coronary care unit after 12 hours were considered cases. Controls included 600 patients treated within 2 hours, 603 between 2 and 6 hours, and 466 between 6 and 12 hours.
RESULTS: The median decision time among cases was 50-fold higher than that of controls who presented within 2 hours. Home-to-hospital time and in-hospital time appeared to play a less important role. Considering the patient-related variables, the delay seemed to be significantly affected by advanced age, living alone, low intensity of initial symptoms, history of diabetes, strong pain at onset of the infarction, occurrence of symptoms at night, and involvement of a general practitioner.
CONCLUSIONS: These data suggest that interventions aimed at reducing the delay in acute myocardial infarction treatment should primarly focus on the help-seeking behaviour of patients.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app